Pulse Pressure Lowering Effect of Dual Blockade With Candesartan and Lisinopril vs. High-dose ACE Inhibition in Hypertensive Type 2 Diabetic Subjects: A CALM II Study Post-hoc Analysis | Zendy

Søren Tang Knudsen | Zendy; N.H. Andersen | Zendy; Steen Hvitfeldt Poulsen | Zendy; Hans Eiskjær | Zendy; Klavs Würgler Hansen | Zendy; Kjeld Helleberg | Zendy; P. L. Poulsen | Zendy; C. E. Mogensen | Zendy

Open Access

Pulse Pressure Lowering Effect of Dual Blockade With Candesartan and Lisinopril vs. High-dose ACE Inhibition in Hypertensive Type 2 Diabetic Subjects: A CALM II Study Post-hoc Analysis

Author(s) -

Søren Tang Knudsen,

N.H. Andersen,

Steen Hvitfeldt Poulsen,

Hans Eiskjær,

Klavs Würgler Hansen,

Kjeld Helleberg,

P. L. Poulsen,

C. E. Mogensen

Publication year - 2008

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1038/ajh.2007.2

Subject(s) - lisinopril , candesartan , medicine , ambulatory blood pressure , blood pressure , post hoc analysis , blockade , ace inhibitor , type 2 diabetes , microalbuminuria , urology , cardiology , placebo , endocrinology , diabetes mellitus , angiotensin ii , angiotensin converting enzyme , receptor , alternative medicine , pathology

Elevated pulse pressure (PP) is strongly associated with micro- and macrovascular complications in type 2 diabetic patients. We examined the effect of 12 months of dual blockade with candesartan and lisinopril vs. high-dose lisinopril monotherapy on ambulatory PP in hypertensive type 2 diabetic patients from the CALM (Candesartan and Lisinopril Microalbuminuria Trial) II study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research